Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis.

Background and aim: Globally, nearly one in five people who inject drugs (PWID) are living with HIV, and the rate of new HIV infections in PWID is increasing in some settings. Early diagnosis is crucial for effective HIV control. We reviewed the evidence on the association between opioid agonist the...

Descripción completa

Detalles Bibliográficos
Publicado en:Addiction Vol. 116; no. 7; pp. 1664 - 1677
Autores principales: Ferraro, Claire F., Stewart, Daniel E., Grebely, Jason, Tran, Lucy T., Zhou, Shally, Puca, Carla, Hajarizadeh, Behzad, Larney, Sarah, Santo, Thomas, Higgins, Julian P. T., Vickerman, Peter, Degenhardt, Louisa, Hickman, Matthew, French, Clare E.
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: Wiley-Blackwell Jul2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150671468&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150671468
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: Jul2021
      vid: 116
      iid: 7
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        150671468
        148582628
        150671468
        150671468
        10.1111/add.15316
        150671468
      ppf: 1664
      ppct: 13
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis.
      aug:
        au:
          Ferraro, Claire F.
          Stewart, Daniel E.
          Grebely, Jason
          Tran, Lucy T.
          Zhou, Shally
          Puca, Carla
          Hajarizadeh, Behzad
          Larney, Sarah
          Santo, Thomas
          Higgins, Julian P. T.
          Vickerman, Peter
          Degenhardt, Louisa
          Hickman, Matthew
          French, Clare E.
        affil: Health Protection Research Unit, Population Health Sciences, University of Bristol, Canynge Hall, 39 Whatley Road, Clifton, Bristol, BS8 2PS,, UK
      sug:
        subj:
          Substance Use Disorders Drug Therapy
          Analgesics, Opioid Therapeutic Use
          HIV Infections Diagnosis
          Health Screening
          Persons Who Use Intravenous Drugs
          Human
          Systematic Review
          Meta Analysis
          Checklists
          Methadone
          Buprenorphine
      ab: Background and aim: Globally, nearly one in five people who inject drugs (PWID) are living with HIV, and the rate of new HIV infections in PWID is increasing in some settings. Early diagnosis is crucial for effective HIV control. We reviewed the evidence on the association between opioid agonist therapy (OAT) and HIV testing uptake among PWID. Methods: We conducted a systematic review searching MEDLINE, Scopus, Web of Science, Cochrane Central Register of Controlled Trials and PsycINFO for studies published from January 2000 to March 2019. Reference lists and conference proceedings were hand‐searched. Observational and intervention studies were eligible for inclusion. Risk of bias was assessed using the Risk of Bias in Non‐Randomised Studies of Interventions (ROBINS‐I) tool. Meta‐analyses were conducted using random‐effects models. Results: Of 13 373 records identified, 11 studies from Australia, Europe, Malaysia and the United States were included. All studies had at least a serious risk of bias, largely due to confounding and selection bias, making it difficult to draw causal conclusions from the evidence. Ten studies provided data on the association between current OAT use and recent HIV testing. Six showed a positive association, while four provided little evidence of an association: pooled odds ratio (OR) = 1.71, 95% confidence interval (CI) = 1.28–2.27. Looking at having ever been on OAT and having ever been HIV tested, seven studies showed a positive association and three showed either weak or no evidence of an association: pooled OR = 3.82, 95% CI = 2.96–4.95. Conclusions: Opioid agonist therapy may increase uptake of HIV testing among people who inject drugs, providing further evidence that opioid agonist therapy improves the HIV treatment care cascade.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N